Insider Holders & Insider Ownership - CTI BIOPHARMA CORP (CTIC)

List of insiders holdings for CTI BIOPHARMA CORP:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Baxter Healthcare SA
10% Owner		2015-05-01 17:23:0715,673,981
0		15,673,981Form 4
Baxter Healthcare SA
BAXTER INTERNATIONAL INC
10% Owner		2015-05-01 17:21:3515,673,981
0		15,673,981Form 13G
BIANCO JAMES A
Director		2016-10-03 20:39:146,539,290
0		6,539,290Form 4
ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
10% Owner		2021-12-06 16:25:164,024,821
0		4,024,821Form 13G
ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ISALY SAMUEL D
10% Owner		2021-12-06 16:25:164,024,821
0		4,024,821Form 13G
BENNER STEVEN E
EVP, Chief Medical Officer		2013-03-22 17:53:27616,809
33,334		650,143Form 4
BIANCO LOUIS A
EVP, Finance & Administration		2016-03-23 18:36:46622,933
37		622,970Form 4
GREGORIAN VARTAN
Director		2014-03-28 18:41:16468,937
0		468,937Form 4
MUNDINGER MARY ONEIL
Director		2016-04-29 17:45:19360,019
0		360,019Form 4
Eramian Daniel G
EVP, Corporate Communications		2012-09-21 19:35:26354,350
0		354,350Form 4
SEELEY BRUCE J.
EVP, Chief Operating Officer		2022-03-11 19:40:31323,905
0		323,905Form 4
SPINELLI SILVANO
EVP, Development		2005-03-02 17:08:04125,000
0		125,000Form 4
SINGER JACK W
EVP, Chief Scientific Officer		2018-05-17 16:25:0994,433
0		94,433Form 4
LOVE RICHARD L
Director		2017-10-02 17:25:0373,718
0		73,718Form 4
LINK MAX
Director		2005-10-04 18:33:3173,572
0		73,572Form 4
NUDELMAN PHILLIP M PHD
Director		2017-05-02 17:46:3773,129
0		73,129Form 4
STROMATT SCOTT
EVP,Clinical Dev & Reg Affair		2008-04-08 17:30:5165,786
0		65,786Form 4
Ignagni Karen
Director		2015-09-25 18:18:5763,695
0		63,695Form 4
BAUER JOHN H
Director		2015-09-25 18:33:0163,695
0		63,695Form 4
Plunkett Matthew
EVP, Chief Business Officer		2017-03-06 16:59:0660,000
0		60,000Form 4
Telling Fred
Director		2018-09-20 16:23:0260,000
0		60,000Form 4
CANFIELD JAMES
Chief Administrative Officer		2005-04-05 20:59:2639,499
0		39,499Form 4
KENNEY EDWARD F
EVP, Chief Operating Officer		2004-01-05 18:27:0425,374
0		25,374Form 4
SUTTER MARTIN P
Director		2003-11-14 14:36:3425,000
0		25,000Form 4
ASELAGE STEVE
EVP, Global Commercial Ops		2005-07-05 20:30:1424,133
0		24,133Form 4
Leigh Richard JR
EVP, General Counsel		2005-09-15 17:06:3013,300
0		13,300Form 4
Brown Jade
EVP, Chief Business Officer		2006-10-30 19:31:0810,667
0		10,667Form 4
FLUKE JOHN M JR
Director		2005-03-16 18:19:2310000
0		10000Form 4
PLATZER ERICH
Director		2005-01-04 19:44:0410000
0		10000Form 4
BOWMAN JACK L
Director		2004-04-23 17:38:4010000
0		10000Form 4
PHILIPS CRAIG
Former President		2012-11-19 21:07:09414
0		414Form 4
BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
See Remarks
10% Owner		2023-06-28 18:26:130
0		0Form 4
PERRY MATTHEW D
Director		2023-06-26 16:05:420
0		0Form 4
Parks Diane L.
Director		2023-06-26 16:05:380
0		0Form 4
Fischer Laurent
Director		2023-06-26 16:05:310
0		0Form 4
Tuckson Reed Vaughn
Director		2023-06-26 16:05:250
0		0Form 4
Metzger Michael A
Director		2023-06-26 16:05:230
0		0Form 4
Parkinson David Ross
Director		2023-06-26 16:05:210
0		0Form 4
KIRSKE DAVID
EVP, Chief Financial Officer		2023-06-26 16:05:210
0		0Form 4
Craig Adam R
President and CEO		2023-06-26 16:05:160
0		0Form 4
Fong James K
EVP & Chief Commercial Officer		2023-06-26 16:05:100
0		0Form 4